Addus HomeCare Co. (NASDAQ:ADUS) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Addus HomeCare Co. (NASDAQ:ADUS) has received an average recommendation of “Moderate Buy” from the seven analysts that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation and six have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $103.00.

ADUS has been the topic of several research analyst reports. Barclays cut Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target on the stock. in a report on Tuesday, April 23rd. Royal Bank of Canada reissued an “outperform” rating and issued a $102.00 target price on shares of Addus HomeCare in a research report on Thursday, February 29th. William Blair reaffirmed an “outperform” rating on shares of Addus HomeCare in a research report on Monday, February 5th. Finally, Oppenheimer reissued an “outperform” rating and issued a $118.00 price objective on shares of Addus HomeCare in a report on Tuesday, March 26th.

Addus HomeCare Price Performance

ADUS opened at $96.15 on Friday. The company’s 50-day simple moving average is $97.69 and its two-hundred day simple moving average is $91.88. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38. The stock has a market capitalization of $1.57 billion, a P/E ratio of 25.04, a P/E/G ratio of 1.86 and a beta of 0.95. Addus HomeCare has a 52-week low of $77.30 and a 52-week high of $104.61.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, February 26th. The company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.17. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. The company had revenue of $276.35 million for the quarter, compared to the consensus estimate of $274.02 million. As a group, analysts predict that Addus HomeCare will post 4.38 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. Principal Securities Inc. bought a new position in shares of Addus HomeCare during the 4th quarter valued at approximately $26,000. BluePath Capital Management LLC purchased a new position in Addus HomeCare during the third quarter valued at approximately $31,000. GAMMA Investing LLC bought a new position in shares of Addus HomeCare in the fourth quarter worth approximately $34,000. Assetmark Inc. boosted its position in shares of Addus HomeCare by 17.1% in the third quarter. Assetmark Inc. now owns 1,331 shares of the company’s stock worth $113,000 after purchasing an additional 194 shares during the period. Finally, DekaBank Deutsche Girozentrale purchased a new stake in shares of Addus HomeCare in the third quarter worth $189,000. Institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.